Public Health

Resource Center

FDA Alerts

FDA ALERT

FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions

11/08/2015

Anthony Calabro, MA

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

11/08/2015

Research Summaries

Conference Coverage

Fatigue, Headache Are Primary Symptoms of Long COVID Among Patients 21 Years of Age or Younger

10/07/2024

Anthony Calabro, MA

Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.

10/07/2024

FDA Alert

FDA Alert

FDA Approves First Antipsychotic Medication Targeting Cholinergic Receptors for Patients with Schizophrenia

09/30/2024

Miranda Manier, BA

Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.

09/30/2024

FDA Alert